JP2023518249A5 - - Google Patents
Info
- Publication number
- JP2023518249A5 JP2023518249A5 JP2022555959A JP2022555959A JP2023518249A5 JP 2023518249 A5 JP2023518249 A5 JP 2023518249A5 JP 2022555959 A JP2022555959 A JP 2022555959A JP 2022555959 A JP2022555959 A JP 2022555959A JP 2023518249 A5 JP2023518249 A5 JP 2023518249A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- group
- hydrogen
- independently selected
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062990337P | 2020-03-16 | 2020-03-16 | |
| US62/990,337 | 2020-03-16 | ||
| PCT/US2021/022622 WO2021188586A1 (en) | 2020-03-16 | 2021-03-16 | Method of treating viral infections with hexose type monosaccharides and analogs thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518249A JP2023518249A (ja) | 2023-04-28 |
| JP2023518249A5 true JP2023518249A5 (https=) | 2024-03-19 |
Family
ID=75439533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555959A Pending JP2023518249A (ja) | 2020-03-16 | 2021-03-16 | ヘキソース型単糖およびその類縁体による、ウイルス感染症の処置方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230130134A1 (https=) |
| EP (1) | EP4121060A1 (https=) |
| JP (1) | JP2023518249A (https=) |
| KR (1) | KR20220166800A (https=) |
| CN (1) | CN115515601A (https=) |
| AU (1) | AU2021239927A1 (https=) |
| BR (1) | BR112022018536A2 (https=) |
| CA (1) | CA3170872A1 (https=) |
| IL (1) | IL296389A (https=) |
| MX (1) | MX2022011488A (https=) |
| WO (1) | WO2021188586A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024118503A1 (en) | 2022-11-28 | 2024-06-06 | Hongene Biotech Corporation | Functionalized n-acetylgalactosamine analogs |
| EP4582080A1 (en) | 2024-01-02 | 2025-07-09 | G.ST Antivirals GmbH | Dispenser for mucosal administration comprising 2-deoxy-glucose or analogues thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6670330B1 (en) | 2000-05-01 | 2003-12-30 | Theodore J. Lampidis | Cancer chemotherapy with 2-deoxy-D-glucose |
| WO2004007747A2 (en) * | 2002-07-12 | 2004-01-22 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Assays for assembly of ebola virus nucleocapsids |
| WO2004062604A2 (en) | 2003-01-10 | 2004-07-29 | Threshold Pharmaceuticals, Inc. | Treatment of cancer with 2-deoxyglucose |
| BRPI0708273A2 (pt) * | 2006-02-24 | 2011-05-24 | Univ Texas | uso de compostos de hexoses |
| WO2009108926A1 (en) | 2008-02-29 | 2009-09-03 | Board Of Regents, The University Of Texas System | Inhibitors of glycolysis useful in the treatment of brain tumors |
| WO2008131024A1 (en) | 2007-04-17 | 2008-10-30 | Board Of Regents, The University Of Texas System | Iodo-hexose compounds useful to treat cancer |
| ES2628180T3 (es) | 2008-07-11 | 2017-08-02 | Board Of Regents, The University Of Texas System | Nuevos acetatos de 2-desoxi monosacáridos con actividad anticancerosa |
| WO2010115184A2 (en) * | 2009-04-03 | 2010-10-07 | Achillion Pharmaceuticals, Inc. | Hydroxythienoquinolones and related compounds as anti-infective agents |
| WO2012097052A2 (en) * | 2011-01-11 | 2012-07-19 | Intertech Bio, Llc | Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases |
| EP3517117A1 (en) * | 2018-01-30 | 2019-07-31 | Medizinische Universität Wien | Medicament for prevention or treatment of rhinovirus infection |
-
2021
- 2021-03-16 BR BR112022018536A patent/BR112022018536A2/pt unknown
- 2021-03-16 MX MX2022011488A patent/MX2022011488A/es unknown
- 2021-03-16 AU AU2021239927A patent/AU2021239927A1/en active Pending
- 2021-03-16 JP JP2022555959A patent/JP2023518249A/ja active Pending
- 2021-03-16 CN CN202180032098.7A patent/CN115515601A/zh active Pending
- 2021-03-16 US US17/906,459 patent/US20230130134A1/en active Pending
- 2021-03-16 WO PCT/US2021/022622 patent/WO2021188586A1/en not_active Ceased
- 2021-03-16 CA CA3170872A patent/CA3170872A1/en active Pending
- 2021-03-16 KR KR1020227034683A patent/KR20220166800A/ko active Pending
- 2021-03-16 EP EP21717687.4A patent/EP4121060A1/en active Pending
- 2021-03-16 IL IL296389A patent/IL296389A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021063088A5 (https=) | ||
| KR102318320B1 (ko) | 고양이 코로나바이러스 감염의 치료 방법 | |
| JP2024170583A5 (https=) | ||
| JP2005526107A5 (https=) | ||
| JP2023002662A5 (https=) | ||
| JP2024516371A5 (https=) | ||
| JP2023518249A5 (https=) | ||
| JP2002501049A5 (https=) | ||
| JP2005533021A5 (https=) | ||
| JP2004509061A5 (https=) | ||
| JP2009538327A5 (https=) | ||
| JP2014530874A5 (https=) | ||
| JP2021102643A5 (https=) | ||
| JP2021521118A5 (https=) | ||
| JP2008534453A5 (https=) | ||
| JP2009521473A5 (https=) | ||
| JP2002528502A5 (https=) | ||
| JP2019533660A5 (https=) | ||
| JP2022534776A5 (https=) | ||
| JP2008510758A5 (https=) | ||
| JP2024541569A5 (https=) | ||
| JP2021534160A5 (https=) | ||
| JPWO2023054732A5 (https=) | ||
| JP2022551691A5 (https=) | ||
| BRPI0610873A2 (pt) | tratamento de doenças hepáticas em que o ferro desempenhe um papel na patogênese |